The document discusses computational modeling of drug disposition. It covers modeling of drug absorption, distribution, excretion, and active transport. For drug absorption, it describes modeling of solubility, intestinal permeability, and transporters involved. It also discusses modeling approaches for distribution processes like volume of distribution, plasma protein binding, and blood-brain barrier permeability. Current challenges include better incorporating the effects of active transporters in models. The document emphasizes that while computational models are useful for predicting drug properties, fully accounting for complex biological factors remains difficult.
Computational modelling of drug disposition lalitajoshi9
computational modelling of drug disposition is the integral part of computer aided drug design. different kinds of tools being used in the prediction of drug disposition in human body. This topic in the CADD explains the details about the drug disposition, active transporters and tools.
Statistical modeling in pharmaceutical research and developmentPV. Viji
Statistical modeling in pharmaceutical research and development , Statistical Modeling , Descriptive Versus Mechanistic Modeling , Statistical Parameters Estimation , Confidence Regions , Non Linearity at the Optimum , Sensitivity Analysis , Optimal Design , Population Modeling
Computational modelling of drug disposition lalitajoshi9
computational modelling of drug disposition is the integral part of computer aided drug design. different kinds of tools being used in the prediction of drug disposition in human body. This topic in the CADD explains the details about the drug disposition, active transporters and tools.
Statistical modeling in pharmaceutical research and developmentPV. Viji
Statistical modeling in pharmaceutical research and development , Statistical Modeling , Descriptive Versus Mechanistic Modeling , Statistical Parameters Estimation , Confidence Regions , Non Linearity at the Optimum , Sensitivity Analysis , Optimal Design , Population Modeling
REGULATORY AND INDUSTRY VIEWS ON QbD, SCIENTIFICALLY BASED QbD- EXAMPLES OF A...Ardra Krishna
The pharmaceutical Quantity by Design (QbD) is a systemic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quantity risk management.
QbD has been adopted by U.S Food and Drug Administration (FDA) for the discovery, development and manufacture of drugs.
Quality- by- design (QbD) is a concept introduces by the International Conference on Harmonization (ICH) Q8 guidelines.
Myself Omkar Tipugade , M- Pharm ,Sem - II, Department of pharmaceutics , from Shree Santkrupa College Of Pharmacy , ghogaon . Today I upload presentation on Active Transport like P-gp , BCPR, Nucleoside transporters etc .
Computational modeling of drug dispositionPV. Viji
Computational modeling of drug disposition , Modeling techniques , Drug absorption , solubility , intestinal permeation , Drug distribution , Drug excretion , Active Transport , P-gp , BCRP , Nucleoside transporters , hPEPT1 , ASBT , OCT , OATP , BBB-choline transporter
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...PRAJAKTASAWANT33
Introduction, biopharmaceutic factors affecting drug bioavailability, rate–limiting steps in drug absorption, physicochemical nature of the drug formulation factors affecting drug product performance
Myself Omkar Tipugade , M - Pharm sem II , department of Pharmaceutics , today will upload presentation on Computational modeling in drug disposition .
REGULATORY AND INDUSTRY VIEWS ON QbD, SCIENTIFICALLY BASED QbD- EXAMPLES OF A...Ardra Krishna
The pharmaceutical Quantity by Design (QbD) is a systemic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quantity risk management.
QbD has been adopted by U.S Food and Drug Administration (FDA) for the discovery, development and manufacture of drugs.
Quality- by- design (QbD) is a concept introduces by the International Conference on Harmonization (ICH) Q8 guidelines.
Myself Omkar Tipugade , M- Pharm ,Sem - II, Department of pharmaceutics , from Shree Santkrupa College Of Pharmacy , ghogaon . Today I upload presentation on Active Transport like P-gp , BCPR, Nucleoside transporters etc .
Computational modeling of drug dispositionPV. Viji
Computational modeling of drug disposition , Modeling techniques , Drug absorption , solubility , intestinal permeation , Drug distribution , Drug excretion , Active Transport , P-gp , BCRP , Nucleoside transporters , hPEPT1 , ASBT , OCT , OATP , BBB-choline transporter
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...PRAJAKTASAWANT33
Introduction, biopharmaceutic factors affecting drug bioavailability, rate–limiting steps in drug absorption, physicochemical nature of the drug formulation factors affecting drug product performance
Myself Omkar Tipugade , M - Pharm sem II , department of Pharmaceutics , today will upload presentation on Computational modeling in drug disposition .
DRUG DISPOSITION COMPUTATIONAL MODELING.pptxManshiRana2
Drug development has traditionally focused entirely on efficacy and selectivity against the biological target.
As a result, roughly 50% of drug candidates fail in phase ii and phase iii clinical trials due to unfavorable pharmacokinetic features, such as absorption, distribution, metabolism, excretion, and toxicity (admet).
Since the mid-1990s, the pressure to control the rising cost of new medication development has shifted the paradigm.
Invitro evaluation of admet characteristics in the early phases of drug discovery has been widely adopted to avoid attrition at more expensive later stages.
COMPUTATIONAL MODELING OF DRUG DISPOSITION.pptxPoojaArya34
Computational modelling of drug disposition is the integral part of computer aided drug design. different kinds of tools being used in the prediction of drug disposition in human body. This topic in the CADD explains the details about the drug disposition, active transporters and tools.
Historically, drug discovery has focused almost exclusively on efficacy and selectivity against the biological target.
As a result, nearly half of drug candidates fail at phase II and phase III clinical trials because of undesirable drug pharmacokinetics properties, including absorption, distribution, metabolism, excretion, and toxicity (ADMET).
The pressure to control the escalating cost of new drug development has changed the paradigm since the mid-1990s. To reduce the attrition rate at more expensive later stages, in vitroevaluation of ADMET properties in the early phase of drug discovery has been widely adopted.Many high-throughput in vitro ADMET property screening assays have been developed and applied successfully .
For example, Caco-2 and MDCK cell monolayers are widely used to simulate membrane permeability as an in vitro estimation of in vivo absorption.
These in vitro results have enabled the training of in silico models, which could be applied to predict the ADMET properties of compounds even before they are synthesized.
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxMO.SHAHANAWAZ
Detail about PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW MOLECULES AND IT’S IMPORTANCE IN DRUG DISCOVERY, including DESCRIPTORS OF ADMET PREDICTION, DATASETS USED IN ADMET PREDICTION
computational modeling of drug disposition Naveen Reddy
Computational Modelling of Drug disposition, modelling techniques, drug absorption, drug distribution, drug Excretion, quantitative approach, qualitative approach, in silico models, blood brain barrier, plasma protein binding, QSAR, QSPR, Volume of distribution
• In silico (literally alluding the mass use of silicon for semiconductor computer chips) is an expression used to performed on computer or via computer simulation
• In silico tools capable of identifying critical factors (i.e. drug physicochemical properties, dosage form factors) influencing drug in vivo performance, and predicting drug absorption based on the selected data set (s) of input factors.
INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION Ram Kanth
Greetings!
Good Day to All..
This presentation is all about the Introduction of Biopharmaceutics and Absorption.
The detailed discussion about the various definitions in relation to Biopharmaceutics. Also it includes the introduction to Absorption of drug, Plasma drug Conc. Vs Time Profile and about Cell membrane - its structure and functions.
Your suggestion and comments are welcome for further improvement in my presentations.
Thank you all for your valuable time.
Disclaimer Note: Some contents in the presentation were taken from online sources which is purely used for education purpose and for any personal financial or commercial aspects. I thank all the source providers in online for your efforts and support in sharing of knowledge.
The complex interplay between liver metabolising enzymes and transportersTorben Haagh
The interplay between liver metabolising enzymes and transporters is a complex process. To address this, Ms. Neuhoff together with other experts in the field published a white paper on the mechanistic framework for in vitro–in vivo extrapolation of liver membrane transporters and their interplay with liver metabolizing enzymes. Read more about the methods used and conclusions in the whitepaper below: "A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine": http://bit.ly/Slideshare_NeuhoffWP
Similar to Computational modeling in drug disposition (20)
brief overview on oligonucleotide, oligonucleoside and its application in medicine. given the basic knowledge as well about the DNA and its composition.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Evaluation of antidepressant activity of clitoris ternatea in animals
Computational modeling in drug disposition
1. Computational Modeling in
Drug Disposition
HIMAL BARAKOTI
M.PHARM, 2ND SEM
FACULTY OF PHARMACEUTICAL SCIENCE
ASSAM DOWN TOWN UNIVERSITY
2. Contents
Introduction
Modeling Technique
Drug Absorption
(Solubility and Intestinal Permeation)
Drug Distribution
Drug Excretion
Active Transport
(P-gp, BCRP, Nucleoside Transporters, hPEPT1, ASBT, OCT,
OACP, BBB-Choline Transporter)
Current Challenges and future Directions
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 2
3. Introduction
Historically, drug discovery has focused almost exclusively on efficacy and selectivity against
the biological target.
As a result, nearly half of drug candidates fail at phase II and phase III clinical trials because of
the undesirable drug pharmacokinetics properties, including absorption, distribution,
metabolism, excretion and toxicity (ADMET).
The pressure to control the escalating cost of new drug development has changed the
paradigm since the mod-1990s.
To reduce the attrition rate at more expensive later stages, in vitro evaluation of ADMET
properties in the early phase of drug discovery has widely adopted.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 3
4. Many high-throughput in vitro ADMET property screening assays have been developed and
applied successfully.
Fueled by the ever-increasing computational power and significant advances of in silico
modeling algorithms, numerous computational programs that aim at modeling ADMET
properties have emerged.
A comprehensive list of available commercial ADMET modeling software has been provided till
date.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 4
5. Modeling technique: 2 Approaches
The quantitative approaches represented by pharmacophore modeling and flexible docking
studies investigate the structural requirements for the interaction between drugs and the
targets that are involved in ADMET processes.
These are especially useful when there is an accumulation of knowledge against certain target.
For example, a set of drugs known to be transported by a transporter would enable a
pharmacophore study to elucidate the minimum required structural features for transport.
Three widely used automated pharmacophore perception tools are DISCO (DIStance
COmparisons), GASP (Genetic Algorithm Similarity Program) and Catalyst/HIPHOP.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 5
6. The qualitative approaches represented by quantitative structure-activity relationship (QSAR)
and quantitative structure-property relationship (QSPR) studies utilize multivariate analysis to
correlate molecular descriptors with ADMET-related properties.
A diverse range of molecular descriptors can be calculated based on the drug structure. Some
of these descriptors can be calculated based on drug structure.
It is essential to select the right mathematical tool for most effective ADMET modeling.
Sometimes it is necessary to apply multiple statistical methods and compare the results to
identify the best approach.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 6
8. Drug Absorption
Because of its convenience and good patient compliance, oral administration is the most
preferred drug delivery form.
As a result, much of the attention of in silico approaches is focused on modeling drug oral
absorption, which mainly occurs in the human intestine.
In general, drug bioavailability and absorption is the result of the interplay between drug
solubility and intestinal permeability.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 8
9. a) Solubility
A drug generally must dissolve before it can be absorbed from the intestinal lumen.
By measuring a drug’s logP value (log of partition coefficient of compound between water and
n-octanol) and its melting point, one could indirectly estimate solubility using “general solubility
equation”.
To predict the solubility of compound even before synthesizing it, in silico modeling can be
implemented.
There are mainly two approaches to model solubility. One is based on the underlying
physiological processes, and the other is an empirical approach. The dissolution process involves
the breaking up of solute from its crystal lattice and the association of the solute with solvent
molecules.
Empirical approaches, represented by QSPR, utilize multivariate analysis to identify correlations
between molecular descriptors and solubility.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 9
10. b) Intestinal Permeation
Intestinal permeation describes the ability of drugs to cross the intestinal mucosa separating
the gut lumen from the portal circulation.
It is an essential process for drugs to pass the intestinal membrane before entering the
systemic circulation to reach their target site of action.
The process involves both passive diffusion and active transport.
It is a complex process that is difficult to predict solely based on molecular mechanism.
As a result, most current models aim to simulate in vitro membrane permeation of Caco-2,
MDCK or PAMPA, which have been a useful indicator of in vivo drug absorption.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 10
11. Drug Distribution
Distribution is an important aspect of drug’s pharmacokinetic profile.
The structural and physiochemical properties of a drug determine the extent of distribution,
which is mainly reflected by three parameters:
1. volume of distribution (Vd),
2. plasma-protein binding (PPB) and
3. blood-brain barrier (BBB) permeability.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 11
12. Volume of Distribution (Vd)
Vd is a measure of relative partitioning of drug between plasma and tissue, an important
proportional constant that, when combined a drug is a major determinant of how often the drug
should be administered.
However, because of the scarcity of in vivo data and complexity of the underlying processes,
computational models that are capable of prediction Vd based solely on computed descriptors
are still under development.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 12
13. Plasma Protein Binding (PBP)
Drugs binding to a variety of plasma proteins such as serum albumin, as unbound drug
primarily contributes to pharmacological efficacy.
The effect of PPB is an important consideration when evaluating the effective (unbound) drug
plasma concentration.
The models proposed to predict PBB should not rely on the binding data of only one protein
when predicting plasma protein binding because it is a composite parameter reflecting
interactions with multiple protein.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 13
14. Blood-Brain Barrier (BBB)
The BBB maintains the restricted extracellular environment in the central nerve system.
The evaluation of drug penetration through the BBB is an integral part of drug discovery and
development process.
Again, because of the few experimental data derived from inconsistent protocols, most BBB
permeation prediction models are of limited practical use despite intensive efforts.
Most approaches model log blood/brain (logBB), which is a measurement of the drug
partitioning between blood and brain tissue.
The measurement is an indirect implication of BBB permeability, which does not discriminate
between free and plasma protein-bound solute.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 14
15. Drug Excretion
The excretion or clearance of a drug is quantified by plasma clearance, which is defined as
plasma volume that has been cleared completely free of drug per unit of time.
Together with Vd, it can assist in the calculation of drug half-life, thus determining the dosage
regimen.
Hepatic and renal clearances are the two main components of plasma clearance.
No model has been reported that is capable of predicting plasma clearance solely from
computed drug structures.
Current modeling efforts are mainly focused on estimating in vivo clearance from in vitro data.
Just like other pharmacokinetic aspects, the hepatic and renal clearance process is also
complicated by presence of active transporters.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 15
16. Active Transporters
Transporters are an integral part of any ADMET modeling program because of their presence
on barrier membranes and the substantial overlap between their substrates and many drugs.
Unfortunately, because of our limited understanding of transporters, most prediction
programs do not have a mechanism to incorporate the effect of active transport.
However, interest in these transporters has resulted in a relatively large amount of in vitro
data, which in turn have enabled the generation of pharmacophore and QSAR models for many
of them.
These models have assisted in the understanding of the complex effects of transporters on
drug disposition, including absorption, distribution and excretion.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 16
18. Current Challenges and Future Direction
The major recent advancement in ADMET modeling is in elucidating the role and successful
modeling of various transporters.
Incorporation of the influence of these transporters in the current models is an ongoing task in
ADMET modeling.
Some commercial programs have already implemented the capability of modeling active
transport, such as recent version of GastroPlus (Simulation Plus, Lancaster,CA), PK-Slim (Bayer
Technology Services, Germany) and ADME/Tox WEB (Pharma Algorithms, Toronto, Canada).
In the latter software, compounds are first screened against pharmacophore models of
different active transporters. The compound that fits these models is removed for further
predictions, which is based solely on physiochemical properties.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 18
19. Not all pharmaceutical companies can afford the resources to generate their own in-house
modeling programs, so the commercially available in silico modeling suites have become an
attractive option.
Some modeling programs such as Algorithm Builder (Pharma Algorithms, Toronto, Canada) are
offering flexibility for costumers to generate their in-house models with their own training set
and the statistical algorithm of their choice.
These trends will accelerate the shift of model building from computational scientists to
experimental scientists.
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 19
20. References:
Ekins S, “Computer Applications in Pharmaceutical Research and Development”, (2006)
John Wiley and Sons Inc., chapter 20, pp495-508
Ekins S, Nikolsky Y and Nikolskaya T. Techniques: Application of systems biology to
absorption, distribution, metabolism, excretion and toxicity. Trends Pharmacol Sci
2005;26;202-9
https://hemonc.mhmedical.com/content.aspx?bookid=1810§ionid=124489864
(accessed in 13th May, 2018 )
FACULTY OF PHARMACEUTICAL SCIENCE, ADTU 20